Linearis Ventures
VC Fund
Montréal, Canada
Linearis Ventures is a VC fund in Montréal focused on Biotechnology and Medical Device. Linearis Ventures is pioneering and supporting discoveries to prevent, detect and cure diseases through direct investments in innovative life sciences companies. Linearis brings together a team of seasoned experts in biomarker discovery, drug development, BioPharma executives, healthcare innovators, the co-father of modern AI and winner of the A.M.Turing Prize, Dr Yoshua Bengio as well as the curator of the Human Metabolome Database, Dr David Wishart. To fundamentally transform our healthcare systems and improve patient care, we must provide novel, non-invasive and easily accessible modalities for better diagnosis, prediction of health status, optimization of treatments and monitoring. Integrated into the VC fund, Linearis Labs' AI-driven differentiating offering is unique in generating disease signatures tailored to elucidate causal relationships underlying human omics and diseases. Its omic signature AI-tailored approach to cancer, diabetes, infectious diseases, NASH and other chronic diseases will accelerate discovery and commercialize new innovative medicines to improve patient care and outcomes.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Linearis Ventures invests in
Stages Linearis Ventures invests in
Countries Linearis Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alexandre Le Bouthillier
|
|||
Investment Focus
Industry
- Biotechnology 2 (50%)
- Medical Device 2 (50%)
- Artificial Intelligence 2 (50%)
- Medical 1 (25%)
- Software 1 (25%)
Stage
- Pre-Seed 1 (25%)
- Series A 1 (25%)
- Convertible Note 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Canada 3 (75%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alexandre Le Bouthillier
General Partner
|
General Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ScopiaTech revolutionize the operating room with its real-time AI image processing technology. ScopiaTech is a Montreal-based startup developing the world’s first navigation system for laparoscopic surgery, merging pre-op imaging with real time AI & computer vision to guide surgeons during MIS. This enables surgeons to see hidden structuresintraoperatively with augmented reality. ScopiaTech's digital solution is targeted at robotics and laparoscopic procedures in complex pelvic oncologic cases. Our solution provides layers of intelligence to improve visualization, navigation, diagnosis, and intervention. | $1.9M / Pre-Seed / Sep 01, 2026 | ||
| Zilia has developed a non-invasive platform technology that uses imaging, spectrometry and artificial intelligence to quantitatively measure different biomarkers in the human eye. Zilia’s initial product, Zilia Ocular, is the first retinal camera to quantify oxygen saturation, a crucial biomarker in ocular diseases such as glaucoma, DR and AMD.Zilia aims to revolutionize the prevention, diagnosis and management of these diseases by generating actionable data about the eye’s metabolic activity. | Convertible Note / May 07, 2025 | ||
| Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle. | Venture - Series Unknown / Feb 18, 2025 | ||
| Noetik is an AI-native biotechnology company. Noetik leverages in advanced machine learning methods to discover and develop cancer immunotherapies. | $40M / Series A / Aug 28, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Linearis Ventures invest in?
Linearis Ventures invests primarily in Biotechnology, Medical Device and Artificial Intelligence startups, most often at Pre-Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Linearis Ventures?
Public channels for Linearis Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Linearis Ventures?
The team at Linearis Ventures includes Alexandre Le Bouthillier (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
